A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients with Major Depression

Evidence has shown considerable individual variability in bacterial content of the gut microbiota, which is hypothesized to influence brain function. Research examining this relationship suggests that microbiota transplantation may aid in improving depression symptoms by recolonizing the gastrointestinal tract with healthy bacteria. The study will examine the effects of a microbial therapeutic composed of various […]

Read More
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People with Major Depression and/or Generalized Anxiety Disorder

The gut-brain axis is being heavily explored in current neuropsychiatric research. Evidence has shown considerable individual variability in bacterial content of the gut microbiota, which is hypothesized to influence brain function. Preclinical and clinical research examining this relationship suggests that fecal microbiota transplant (FMT) may aid in improving depression and anxiety symptoms by recolonizing the […]

Read More